Quince Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QNCX and other ETFs, options, and stocks.

About QNCX

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes EryDex, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. 

CEO
Dirk Thye
CEODirk Thye
Employees
36
Employees36
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2012
Founded2012
Employees
36
Employees36

QNCX Key Statistics

Market cap
54.10M
Market cap54.10M
Price-Earnings ratio
-0.94
Price-Earnings ratio-0.94
Dividend yield
Dividend yield
Average volume
85.48K
Average volume85.48K
High today
$1.25
High today$1.25
Low today
$1.13
Low today$1.13
Open price
$1.13
Open price$1.13
Volume
45.68K
Volume45.68K
52 Week high
$2.45
52 Week high$2.45
52 Week low
$0.5116
52 Week low$0.5116
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.